Corazon Dating Sanders's most recent trade in Ultragenyx Pharmaceutical Inc. was a trade of 2,405 Common Stock done at an average price of $37.4 . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical ... | Corazon Dating Sanders | Director | Sale of securities on an exchange or to another person at price $ 37.39 per share. | 20 Jun 2025 | 2,405 | 15,344 (0%) | 0% | 37.4 | 89,923 | Common Stock |
| BeiGene Ltd - ADR | Corazon Dating Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 22,750 | 22,750 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd - ADR | Corazon Dating Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 10,985 | 57,226 (0%) | 0% | 0 | Ordinary Shares | |
| Ultragenyx Pharmaceutical ... | Corazon Dating Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 10,787 | 10,787 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Corazon Dating Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 5,740 | 17,749 (0%) | 0% | 0 | Common Stock | |
| Molecular Templates Inc | Corazon Dating Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2024 | 1,000 | 1,000 | - | - | Stock Option (right to buy) | |
| Ultragenyx Pharmaceutical ... | Corazon Dating Sanders | Director | Sale of securities on an exchange or to another person at price $ 40.98 per share. | 02 Jul 2024 | 584 | 12,009 (0%) | 0% | 41.0 | 23,932 | Common Stock |
| Ultragenyx Pharmaceutical ... | Corazon Dating Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 9,900 | 9,900 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Corazon Dating Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 5,345 | 12,593 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Corazon Dating Sanders | Director | Sale of securities on an exchange or to another person at price $ 41.10 per share. | 10 Jun 2024 | 1,737 | 7,248 (0%) | 0% | 41.1 | 71,391 | Common Stock |
| BeiGene Ltd - ADR | Corazon Dating Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 34,151 | 34,151 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd - ADR | Corazon Dating Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 16,341 | 46,241 (0%) | 0% | 0 | Ordinary Shares | |
| Ultragenyx Pharmaceutical ... | Corazon Dating Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 6,245 | 6,245 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Corazon Dating Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 3,300 | 7,195 (0%) | 0% | 0 | Common Stock | |
| Molecular Templates Inc | Corazon Dating Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Ultragenyx Pharmaceutical ... | Corazon Dating Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 7,255 | 7,255 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Corazon Dating Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 3,895 | 3,895 (0%) | 0% | 0 | Common Stock | |
| Molecular Templates Inc | Corazon Dating Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) |